Gaugene
A high-tech company dedicated to providing excellent hematology testing instruments, reagents and services for in vitro diagnostic users.
Market cap
-
Enterprise valuation
€50—75m (Dealroom.co estimates Jul 2022.)
Beijing China (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
CNY20.2m | Seed | ||
N/A | Seed | ||
CNY100m | Series A | ||
CNY30.0m Valuation: CNY500m | Series A | ||
* | CNY100m | Series B | |
Total Funding | €31.3m |
Related Content
Recent News about Gaugene
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.